UoN experts lead clinical trials for three possible COVID-19 drugs
Medical experts from the University of Nairobi (UoN) are set to conduct clinical trials for three possible coronavirus disease (COVID-19) drugs.
Medical experts from the University of Nairobi (UoN) are set to conduct clinical trials for three possible coronavirus disease (COVID-19) drugs.
The covid-19 pandemic which has ravaged the world in 2020 will be remembered for having caused many unfortunate deaths around the world. In days to come, it will also be remembered for other bad things as well as some good effects in social life and in industries such as education.
The novel coronavirus disease (COVID-19) that has so far infected 2,996,614 people and killed 207,023 others globally continues to pose a great danger to human life.
The University of Nairobi (UoN) College of Health Sciences (CHS) Principal Professor James Machoki has called for increased investment to strengthen the research infrastructure and capacity of Kenyan universities in the wake of coronavirus disease (COVID-19).
According to Prof. Machoki, there is need to carry out Covid-19-related research that covers scientific, medical, economic, behavioural and communication areas.
The University of Nairobi (UoN) Vice Chancellor Prof. Stephen Kiama paid a visit to the College of Health Sciences (CHS) to familiarize himself with the University’s support to the government’s response to the coronavirus disease (COVID-19) pandemic.
We are currently in the midst of a global pandemic associated with the novel coronavirus disease (COVID-19).
The key to halting the rapid spread of the COVID-19 and ‘flattening the infection curve’ is public adherence to drastic and rapidly evolving public health prevention measures that are now being widely implemented around the world.
Dr. Nasser Nyamweya and Prof. Kennedy Abuga discuss the subject of face-masks which have been the focus of much debate in the ongoing COVID-19 pandemic. Also mentioned are the importance of manufacturing standards and environmental concerns.
Below is their article.
The outbreak of coronavirus (COVID-19) pandemic disrupted so many functions and operations across all sectors in all countries in the world.
Following the announcement of the first COVID-19 case in Kenya, the government directed all learning institutions to be shut down as one of the measures to stop the spread of the disease.
Hand sanitizers are one of the key tools being utilized to control the spread of the novel SARS-CoV-2 (coronavirus). The principle component and active ingredient of hand sanitizers that are recommended for coronaviruses is alcohol at a concentration of at least 60% (v/v). The two formulations developed by the World Health Organization (WHO) are based on either ethanol or isopropyl alcohol. The WHO formulas also include hydrogen peroxide and glycerin as a humectant. Commercial hand sanitizers may contain other additives such as polymeric thickeners (e.g., Carbomer), f
The outbreak of COVID-19 that was initially identified in China in December 2019 continues to grow.
Researchers, scientists and scholars across the globe are working tirelessly to get a cure that will help stop COVID-19.